The choice between Liraglutide and Semaglutide GLP-1 is made after a comprehensive consultation with our healthcare providers, considering the individuals medical history, lifestyle, and personal preferences
These are not exaggerations from anxious patients
We work only with long-established manufacturing partners and maintain clear documentation for every peptide we supply
Diabetes - GLP-1 agonists should be primarily considered in patients with type 2 diabetes with suboptimal glycaemic control despite maximal tolerated dose of metformin (+/- other agents) especially where weight loss is desired and/or significant stroke risk is present
Each supplier is reviewed for reliability, documentation integrity, and transparency in testing
Other non-surgical treatments such as laser treatment, cryotherapy (use of extreme cold), azelaic acid, 5-fluorouracil cream, and chemical peels have been used with varying degrees of success, but there isnt enough consistent data to conclude how effective these treatments can be